𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease

✍ Scribed by Harold M. Aukema; Joy Gauthier; Manon Roy; Yong Jia; Huan Li; Rotimi E. Aluko


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
170 KB
Volume
55
Category
Article
ISSN
1613-4125

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Scope: Dietary soy protein reduces renal disease progression in a number of renal diseases, suggesting that plant compared with animal proteins may be renoprotective. The inclusion of other plant protein sources could enhance compliance of intervention diets, but the effects of other plant protein sources are not known.

Methods and results: Weanling Han:SPRD‐cy rats with experimental polycystic kidney disease were given hemp‐, pea‐ and soy protein‐based diets compared with the standard AIN 93G diet with casein as the protein source. Kidneys from diseased rats given diets which contained soy or hemp protein compared with casein‐based diets were less enlarged, had lower fluid content, smaller cyst volumes, less fibrosis, lower chemokine receptor 2 (CCR2) levels and normalized serum creatinine levels. Soy and hemp protein diets also normalized heart size, which was enlarged in diseased compared with normal rats consuming casein. Kidneys from diseased rats given pea protein compared with casein were more enlarged and had higher fluid content and cyst volumes, despite growing better and having lower serum creatinine and renal chemokine receptor 2 levels, and similar levels of renal fibrosis.

Conclusion: Not all plant proteins are equally protective in experimental kidney disease and associated cardiac hypertrophy.


📜 SIMILAR VOLUMES


Effect of anti-macrophage inflammatory p
✍ Isabel J. Crane; Heping Xu; Ayyakkannu Manivannan; Susan McKillop-Smith; Graeme 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

## Abstract This study has enabled us to identify the influence of the chemokine, macrophage inflammatory protein‐1α (MIP‐1α), on leukocyte behavior at the blood‐retina barrier __in vivo__ and its link with the inflammatory process and disease pathogenesis. MIP‐1α has not previously been thought to